We are live on ! Find out more

1,619 hedge funds and large institutions have $126B invested in Merck in 2014 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 602 increasing their positions, 699 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 53

5% more funds holding in top 10

Funds holding in top 10: 140147 (+7)

0% more call options, than puts

Call options by funds: $950M | Put options by funds: $950M

0% less funds holding

Funds holding: 1,6211,619 (-2)

1% less capital invested

Capital invested by funds: $127B → $126B (-$978M)

1.04% less ownership

Funds ownership: 78.25%77.21% (-1%)

14% less repeat investments, than reductions

Existing positions increased: 602 | Existing positions reduced: 699

Holders
1,619
Holders Change
-2
Holders Change %
-0.12%
% of All Funds
46.95%
Holding in Top 10
147
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+5%
% of All Funds
4.26%
New
65
Increased
602
Reduced
699
Closed
53
Calls
$950M
Puts
$950M
Net Calls
+$352K
Net Calls Change
-$100M
Name Holding Trade Value Shares
Change
Change in
Stake
KFA
1351
Kelleher Financial Advisors
New York
$470K -$55.9K -996 -10%
MWP
1352
MYCIO Wealth Partners
Pennsylvania
$470K
AF
1353
Aldebaran Financial
$468K -$135K -2,403 -23%
CICI
1354
Capital Investment Counsel Inc
North Carolina
$468K -$71.5K -1,274 -13%
MCM
1355
McKinley Capital Management
Alaska
$468K -$168 -3 -0%
WA
1356
Waverly Advisors
Alabama
$467K +$4.1K +73 +0.9%
MWM
1357
Modera Wealth Management
New Jersey
$467K +$53.4K +951 +13%
FMC
1358
First Merchants Corp
Indiana
$466K -$57.4K -1,022 -11%
BRM
1359
Boston Research & Management
Massachusetts
$465K
NES
1360
New England Securities
New York
$454K +$9.49K +169 +2%
CL
1361
Croft-Leominster
Maryland
$453K -$1.52K -27 -0.3%
ZAM
1362
Zevin Asset Management
Massachusetts
$447K
RB
1363
Rodgers Brothers
Pennsylvania
$444K
ST
1364
Sabal Trust
Florida
$441K -$27.7K -494 -6%
FCE
1365
Fiera Capital (Europe)
Cayman Islands
$438K +$41.9K +747 +11%
AC
1366
Alexandria Capital
Virginia
$436K -$168 -3 -0%
SCM
1367
SOL Capital Management
Maryland
$435K -$44.1K -786 -9%
Manulife (Manufacturers Life Insurance)
1368
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$433K +$5.48M +97,515 +1%
BC
1369
Banced Corp
Illinois
$430K -$48K -855 -10%
AB
1370
Atlas Brown
Kentucky
$430K -$13.1K -234 -3%
ZCA
1371
Zeke Capital Advisors
Pennsylvania
$429K
FFA
1372
Fragasso Financial Advisors
Pennsylvania
$429K +$6.85K +122 +2%
GCAC
1373
Guardian Capital Advisors (Canada)
Ontario, Canada
$428K
PAS
1374
Professional Advisory Services
Florida
$428K
TAM
1375
Taurus Asset Management
New York
$428K

MRK Hedge Fund Activity: Q3 2014 in Review

1,619 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2014, worth a combined $126B — down 0.77% from $127B a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new MRK positions and 53 closed out — a net gain of 12 holders — while 602 added to existing stakes and 699 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $434M. The largest seller was Norges Bank, cutting an estimated $1.3B.

  • 1,619 institutional investors held Merck (MRK) as of Q3 2014, down from 1,621 in Q2 2014.
  • Funds reported $126B of Merck stock for Q3 2014, down 0.77% quarter-over-quarter.
  • 65 funds opened new Merck positions in Q3 2014 and 53 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2014 was JP Morgan Chase, an estimated $434M added.
  • The largest Merck seller in Q3 2014 was Norges Bank, an estimated $1.3B sold.

Based on aggregated 13F filings for Q3 2014.